Clinical trial by Michigan Medicine will focus on the remote assessment of the fetal biophysical profile
Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine.